The market for Autoimmune Disease Diagnosis is experiencing rapid growth and is projected to expand from $4.1 billion in 2020 to $6.3 billion by 2025, increasing at an impressive 8.9% annual rate. Several key factors are fueling this market’s expansion.
Rising Autoimmune Disease Rates Drive Demand
Perhaps the biggest driver is the high and increasing prevalence of autoimmune conditions like rheumatoid arthritis, lupus, Sjögren’s syndrome and thyroiditis. As these diseases become more common, the need for accurate diagnostic tests grows correspondingly.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519
Greater Awareness Spurring Testing
Along with higher disease rates, increased public and medical awareness about autoimmune disorders is prompting more patients to seek testing and diagnosis. Extensive research into understanding and treating these conditions is also contributing to market growth.
Consumables Lead Product Segment
When analyzing the product landscape, the consumables and assay kits segment is expected to see the highest growth rates during the forecast period. This can be attributed to frequent new product launches and approvals in this category meeting rising testing demand.
Routine Tests Dominate Test Types
Among the various diagnostic test types, routine laboratory tests like blood work are estimated to experience the highest growth rates going forward. The widespread availability and affordable costs of these standard tests are key advantages driving adoption.
Europe Leads Regional Markets
Regionally, Europe represented the largest autoimmune disease diagnostic market in 2019, followed by Asia Pacific. Europe’s large population of aging patients susceptible to autoimmune conditions is a major factor underpinning the region’s market leadership.
Prominent Market Players
Major companies operating in this space include Thermo Fisher Scientific, Siemens, Abbott, Danaher, Bio-Rad, Grifols, Trinity Biotech and many others. With escalating demand, intense competition can be expected among these firms to supply innovative diagnostic products.
In summary, the autoimmune disease diagnostic market is experiencing robust growth propelled by the increasing prevalence of these conditions, greater awareness spurring more testing, and a product mix catering to rising demand. As the population continues aging and autoimmune disease rates climb further, this market’s expansion trajectory seems poised to continue over the coming years.
